← Evidence map

ArticleDigestive diseases and sciences2026

Recalibrating EVendo for Atezolizumab-Bevacizumab Era Hepatocellular Carcinoma.

Wufei YePubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42185719